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Abstract 
Purpose  To study the correlation of retinal sensitivity with both morphologic changes in 
the macula and status of retinal capillary perfusion, after resolution of the macular edema 
associated with retinal vein occlusion (RVO). 
Methods  Retinal sensitivity in the macular area was examined with the Micro Perimeter 5 
1 in 24 eyes after resolution of the macular edema associated with RVO.  Using 
spectral-domain optical coherence tomography, 6 mm × 6 mm areas of macula were 
examined with 256 sequential horizontal scans.  Condition of the photoreceptor layer 
was evaluated depending upon detection of the junctions between inner and outer 
segments of the photoreceptors (IS/OS).  Fluorescein angiography was performed in 19 10 
eyes. 
Results  Mean retinal sensitivity on the affected side of the retina was significantly 
decreased (p<0.001).  On the affected side, the mean retinal sensitivity within the area 
of deteriorated IS/OS was significantly less (3.8 ± 4.8 dB) than that within areas with 
complete IS/OS (10.1 ± 6.4 dB, p<0.001).  Mean retinal sensitivity within nonperfused 15 
areas was extremely low (0.3 ± 1.3 dB), compared with that in perfused retina (10.9 ± 5.9 
dB, p<0.001).  In eyes with a broken foveal capillary ring (FCR), the marked decline in 
retinal sensitivity was seen within the area where the FCR was broken; this was not seen 
in eyes with an intact FCR. 
Conclusion  Retinal function was decreased markedly in areas with a damaged 20 
photoreceptor layer due to RVO, and was lethally decreased within nonperfused areas. 
Due to the various limitations of the current study, including implementation of fluorescein 
angiography in limited number of eyes, wide range of follow-up, and heterogeneity of 
pretreatments, further prospective studies are necessary to confirm the current findings. 
 25 
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Introduction 
 
Macular edema (ME) is one of the major vision-threatening complications associated with 
retinal vein occlusion (RVO) [1,2].  In RVO, increased intravascular pressure and 
reduced blood flow in the macular capillaries can lead to dysfunction of the endothelial 5 
blood-retinal barrier and to increased vascular permeability, both of which result in ME.  
To date, various treatments have been reported to successfully reduce retinal thickening 
and restore foveal function, which leads to improvement in visual acuity (VA) [1,3-21].  In 
the clinical setting, however, some patients have persistent symptoms, such as 
metamorphopsia, blurred vision, and relative scotoma, despite complete resolution of 10 
their ME and good VA. 
     Optical coherence tomography (OCT) is currently widely used to obtain quantitative 
measurements of the foveal thickness and to detect morphologic changes in the retinal 
architecture.  Due to its high resolution and contrast, OCT allows clinicians to use the 
junctions between the inner and outer segments of the photoreceptors (IS/OS) as a 15 
hallmark of the integrity of the outer photoreceptor layer [22-25].  Thus, the condition of 
the IS/OS in the fovea is reported to be closely related to VA in eyes with various 
conditions, including both resolved and persistent ME associated with RVO [22-24].  
Because VA reflects only foveal function, measurement of VA alone is not sufficient to 
evaluate visual function throughout the macular area after resolution of the ME 20 
associated with RVO. 
     Fundus-related microperimetry (Micro Perimeter 1 [MP1]; Nidek, Gamagori, Japan) 
can be used to obtain reliable quantitative measurements of retinal sensitivity in the 
macula by tracking eye movements [26-29].  With the use of the MP1, retinal sensitivity 
has been reported to be correlated with retinal thickness in the fovea as well as in 25 
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extrafoveal areas of eyes with ME associated with branch retinal vein occlusion (BRVO) 
or diabetic retinopathy [29-35].  Recently, Unoki et al. reported that retinal sensitivity as 
determined by the MP1 was severely decreased in capillary nonperfused areas (NPAs) of 
eyes with diabetic retinopathy [33]. 
     However, little information is available on retinal function of the macula after 5 
complete resolution of the ME associated with RVO.  This study was designed to 
examine retinal sensitivity using the MP1 in eyes with resolved ME secondary to RVO; 
this study was performed to determine any relationships between retinal sensitivity and 
morphologic changes in the retina, especially in its outer aspect, and with the status of 
retinal capillary perfusion.  10 
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Materials and Methods  
 
Patient selection  
 
We retrospectively reviewed the medical records of 30 patients (30 eyes) with resolved 5 
ME associated with RVO who were examined by the MP1 between May 2008 and June 
2009.  Eyes with central retinal vein occlusion were excluded from the current study.  
All eyes had shown marked ME at the initial visit, with foveal thickness greater than 300 
m.  Most eyes had undergone some surgical treatment, and all eyes showed complete 
resolution of their ME at the time of inclusion in the current study.  In this study, ME was 10 
considered to be resolved when foveal thickness was decreased to less than 250 m 
with no cystoid spaces in the macular area and when no recurrence of ME (foveal 
thickness equal to or greater than 250 m, or the reappearance of cystoid spaces or 
subretinal fluid) was seen thereafter.  Eyes with co-existing ocular disease (i.e., 
epiretinal membrane, glaucoma, diabetic retinopathy, or senile cataracts that resulted in 15 
poor-quality OCT images) were excluded from the current study.  This study was 
approved by the Institutional Review Board at Kyoto University Graduate School of 
Medicine and adhered to the tenets of the Declaration of Helsinki. 
 
     All patients had undergone comprehensive ophthalmologic examinations, including 20 
best-corrected VA measurement, slit-lamp biomicroscopy, indirect fundus 
ophthalmoscopy, and OCT examination.  Best-corrected VA was measured with a 
Landolt chart and converted to a logarithm of the minimal angle of resolution (logMAR).  
In each eye, the MP1 measurement was performed after resolution of the ME secondary 
Microperimetry in Retinal Vein Occlusion. Ota et al. Page 7 
to RVO.  OCT examination was performed with the use of a spectral-domain OCT 
(3D-OCT 1000; Topcon, Tokyo, Japan) to evaluate morphologic changes of the retina in 
the larger macular area.  Nineteen of the 24 patients underwent fluorescein angiography 
(FA) with a confocal laser scanning system (HRA-2; Heidelberg Engineering, Heidelberg, 
Germany) after resolution of the ME.  In some cases, we used the data previously 5 
obtained by time-domain OCT (Stratus OCT 3000; Carl Zeiss, Dublin, California, USA). 
 
MP1 measurements  
 
Fundus-monitored microperimetry was performed with the MP1 in all eyes.  The MP1 is 10 
equipped with an automatic tracking system that evaluates every acquired frame for 
shifts in the horizontal and vertical directions of the fundus with respect to a reference 
frame obtained by an infrared camera at the beginning of the examination.  A 
4-2-staircase strategy with Goldmann III size stimulus was used, and 57 stimulus 
locations that covered the central 10 degrees were examined (Fig. 1).  The white 15 
background illumination was set at 1.27 cd/m2.  The differential luminance, defined as 
the difference between stimulus luminance and background luminance, was 127 cd/m2 at 
0 decibel (dB) stimulation, and the maximum stimulus attenuation was 20 dB.  The 
duration of the stimulus was 200 ms, and the fixation target was varied in size according 
to the patient’s VA.  Light stimuli were presented randomly during the examination, and 20 
results were reported in dB.  To more clearly depict the clinical correlation between data 
obtained by microperimetry and actual retinal features, functional results were displayed 
on a color digital retinograph. 
     In the current study, the macular area examined by the MP1 was divided into 3 
regions: the foveal region, the affected side, and the unaffected side.  The foveal region 25 
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consisted of 9 stimulus locations that covered the central 2 degrees.  Outside of the 
fovea, the macula was divided into 2 regions by a horizontal line that passed through the 
fovea.  The affected side and unaffected side of the retina were determined by the 
presence of RVO; each side contained 24 stimulus locations (Fig. 1).  Six eyes were 
excluded from the current study due to poor fixation or extrafoveal fixation. 5 
 
3D-OCT examination  
 
After complete resolution of edema, the macular area of each eye was examined with 
3D-OCT.  A 6 × 6-mm area of the macular region centered on the fovea was examined 10 
with 256 sequential horizontal scans.  Each horizontal scan consisted of 256 axial scans.  
In each eye, the retinal structure of this 6 × 6-mm macular area was evaluated by 
observation of each OCT scan.  In most scans, the IS/OS lines appeared to be intact, 
but some sections showed a focal defect of the IS/OS reflective line.  The OCT 
evaluations were done by a fully trained ophthalmologist (Y.O.) who had no knowledge of 15 
the VA or any other conditions of the eyes; a sequence of OCT scans from each data set 
was examined, and areas with a deteriorated IS/OS were identified on the fundus 
projection images. 
 
Comparison of the results (MP1, 3D-OCT, and FA) 20 
 
After comparing the areas with deteriorated or intact IS/OS, which were determined by 
3D-OCT, with the MP1 results, we noted the retinal sensitivity and condition of the IS/OS 
at each stimulus location in the MP1 examination of each eye.  The fundus projection 
image that indicated the areas with deteriorated IS/OS was projected on the retinal 25 
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sensitivity map obtained with the MP1 and the condition of IS/OS was determined at each 
measurement point.  In addition, in 19 of the 24 eyes on which FA was performed, 
superimposing the MP1 data on the FA image was done to study the correlation between 
the MP1 results and FA findings.  After both the MP1 and FA image had been magnified 
(Fig. 2), the overlay was done by matching the fovea and 2 arteriovenous crossings, 5 
which were located on opposite sides of the fovea.  Based on this composite image, we 
noted retinal sensitivity and status of the retinal perfusion (perfusion or nonperfusion) at 
each stimulus location in the MP1 examination of each eye. 
 
Statistical analysis 10 
 
Statistical analysis was performed using a software designed for this purpose (StatView, 
version 5.0; SAS Institute, Cary, North Carolina, USA).  All values are presented as 
mean ± standard deviation.  The retinal sensitivity obtained with MP1 was compared 
with that determined from the Mann-Whitney U test due to its non-normal distribution.  15 
The Student’s t test was used for comparison of foveal thickness and age.  Categorical 
analysis was performed using the Chi-square test.  A p value of less than 0.05 was 
considered to be statistically significant. 
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Results 
 
In the current study, we examined 24 eyes of 24 patients (10 men and 14 women) who 
experienced resolution of the ME associated with RVO; the patients ranged in age from 
47 to 85 years (66.8 ± 10.1 years).  Table 1 shows the clinical characteristics of all 24 5 
patients.  At the initial visit, all eyes showed marked ME and decreased VA associated 
with acute BRVO (17 eyes) or acute hemi-central vein occlusion (CRVO) (7 eyes).  The 
mean initial VA was 0.49 ± 0.33 (in logMAR), and the mean initial foveal thickness was 
554 ± 97 m.  Treatments for acute ME consisted of intravitreal injection of 
bevacizumab in 16 eyes, sub-tenon injection of triamcinolone acetonide in 2 eyes, pars 10 
plana vitrectomy in 3 eyes, and grid laser photocoagulation in 5 eyes.  No surgical 
treatment was performed in 2 eyes.  After the ME had completely resolved, MP1 
measurement was performed for each patient.  Mean VA at that time was 0.07 ± 0.16 (in 
logMAR), and mean foveal thickness was 210 ± 30 m.  The mean duration from the 
final resolution of ME to the MP1 and OCT examinations was 11.5 ± 6.5 months (3–24 15 
months).   
     MP1 examination showed that retinal sensitivity was markedly decreased on the 
affected side of the retina compared with the unaffected side.  In 1152 stimulus 
locations of 24 eyes (576 on the affected side and 576 on the unaffected side), excluding 
the foveal region, the mean retinal sensitivity on the affected side (8.9 ± 6.6 dB) was 20 
significantly less than that on the unaffected side (15.5 ± 3.5, p < 0.001). 
 The condition of the IS/OS at each stimulus location was determined from a 
sequence of OCT sections (Table 2).  On the unaffected side, only 28 (4.9%) of a total 
of 576 points showed deterioration of the IS/OS.  On the affected side, however, as 
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many as 110 points (19.1%) showed deterioration of the IS/OS, and the number of points 
at which the IS/OS was deteriorated was significantly greater on the affected side than on 
the unaffected side (p < 0.001).  Retinal sensitivity was focally decreased in the areas 
with deteriorated IS/OS (Fig. 3).  Mean retinal sensitivity was the highest in stimulus 
locations on the unaffected side with complete IS/OS, while areas with deteriorated 5 
IS/OS on the affected side showed the lowest sensitivity.  On the affected side of the 
retina, the mean retinal sensitivity at the stimulus locations with deteriorated IS/OS (3.8 ± 
4.8 dB) was significantly less than that at stimulus locations with complete IS/OS (10.1 ± 
6.4 dB, p < 0.001). 
     FA was performed in 19 of the 24 eyes; we studied capillary perfusion status at a 10 
total of 456 stimulus locations on the affected side of the retina (24 locations in each eye) 
(Fig. 2).  Of these 456 locations, 102 were in the nonperfused area and the remaining 
354 were in the perfused area (Table 3).  In the perfused area, retinal sensitivity varied 
from 0 dB to 20 dB, although the mean retinal sensitivity at locations with deteriorated 
IS/OS was significantly less than that in locations with intact IS/OS (p < 0.001).  In 15 
contrast, retinal sensitivity was severely decreased in the nonperfused area (Fig. 4).  
Mean retinal sensitivity at the locations in the nonperfused region was extremely low (0.3 
± 1.3 dB), compared with that in the perfused area (10.9 ± 5.9 dB, p < 0.001).  More 
specifically, all 28 locations with deteriorated IS/OS in the nonperfused area showed a 
value of 0 dB.  In nonperfused areas, the stimulus locations, even those with intact 20 
IS/OS, showed significantly less sensitivity (0.5 ± 1.5 dB) than did points in the perfused 
area with deteriorated IS/OS (5.1 ± 4.9 dB, p < 0.001, Fig. 5). 
     The condition of the foveal capillary ring (FCR) was evaluated in 19 eyes.  Of 
these 19 eyes, 10 had a broken FCR, and it was intact in the other 9 eyes (Table 4).  In 
the current study, the VA logMAR after resolution of the ME was relatively good in both 25 
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groups (0.04 ± 0.21 in eyes with an intact FCR and 0.15 ± 0.12 in eyes with a broken 
FCR).  No statistically significant difference was found between these groups in the 
initial VA (p = 0.13) or VA at resolution of the ME (p = 0.055), which tended to be better in 
eyes with an intact FCR than in those with a broken FCR.  However, mean retinal 
sensitivity within the foveal region (within the central 2 degrees) was significantly poorer 5 
in eyes with a broken FCR (10.9 ± 6.5 dB) than in those with an intact FCR (13.7 ± 4.9 dB, 
p < 0.001).  In eyes with a broken FCR, a marked decline in retinal sensitivity was seen 
in the area where the FCR was broken (Fig. 4), but was not seen in eyes with an intact 
FCR. 
10 
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Discussion 
 
Various treatments are reportedly effective in reducing the ME associated with RVO, 
such as grid laser photocoagulation [1,3-5], pars plana vitrectomy [6-8], and intravitreal 
injections of triamcinolone acetonide [8-14] or bevacizumab [15-21].  After successful 5 
treatment, resolution of the ME often leads to substantial improvement of VA.  In most 
reports, the efficacy of these treatments was evaluated based on a change in the foveal 
thickness as measured by OCT and according to measurement of VA.  However, VA 
reflects only foveal function, and because most of the ME associated with RVO 
encompasses a larger area, VA measurement does not necessarily reflect true loss of VA.  10 
In the clinical setting, even after complete resolution of the ME is obtained, some patients 
have persistent symptoms, such as metamorphopsia, blurred vision, and scotoma.  
Therefore, evaluation of the larger macular area is valuable to better determine visual 
function after resolution of the ME associated with RVO. 
     In the present study, we first investigated the correlation between retinal sensitivity 15 
and condition of the IS/OS in the macular area after resolution of the ME.  On the 
unaffected side of the retina, 95% of the locations showed intact IS/OS; however, 19% of 
locations on the affected side of the retina showed deteriorated IS/OS.  Retinal ischemia 
and swelling in the photoreceptor layer due to acute RVO results in deterioration of the 
photoreceptor cells, which is detected as the deteriorated IS/OS on OCT.  Stimulus 20 
locations in areas with deteriorated IS/OS showed significantly less retinal sensitivity than 
did those with intact IS/OS, so the structural abnormality of the photoreceptor layer in 
eyes with resolved ME causes the focal decrease in retinal function within the larger 
macular area. 
     Recently, Ojima et al. reported that in eyes with resolved central serous 25 
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chorioretinopathy, a defect of the IS/OS showed a focal decrease in retinal sensitivity [26].  
They speculated that this defect might account for the persistent visual disturbance after 
complete resolution of the retinal detachment was obtained.  Routine VA measurement 
does not reflect these small structural and functional abnormalities, even if the patient 
has persistent symptoms.  In the current study, we made similar observations in eyes 5 
after resolution of the ME associated with RVO.  Focal damage of the photoreceptor 
layer, which was detected as deterioration of the IS/OS, may partially account for the 
persistent visual disturbance after resolution of the ME and return of good VA. 
     In addition, we investigated the relationship between retinal sensitivity and retinal 
capillary perfusion.  Mean retinal sensitivity within the nonperfused area was 10 
substantially reduced to 0.3 ± 1.3 dB, which was markedly less than that in the perfused 
area (10.9 ± 5.9 dB).  In nonperfused areas, the stimulus locations, even those with 
intact IS/OS, had only 0.5 ± 1.5 dB retinal sensitivity, while all the locations with 
deteriorated IS/OS had a retinal sensitivity of 0 dB (absolute scotoma).  With the use of 
the Humphrey field analyzer, Chee and Flanagan previously reported reduced retinal 15 
sensitivity within areas of capillary nonperfusion in diabetic retinopathy [36].  In eyes 
with diabetic retinopathy and those with acute BRVO, Bell and Feldon reported a good 
correspondence between regional visual field sensitivities and retinal capillary perfusion 
[37].  Our finding is consistent with these previous reports: retinal sensitivity in 
nonperfused areas was extremely low even after complete resolution of both the retinal 20 
hemorrhage and the edema. 
     In eyes with diabetic retinopathy, Unoki et al. recently have shown that the inner 
retina was thinner and more disorganized in nonperfused areas than in perfused retinal 
areas [33].  The inner retina would be particularly at risk to hypoxic insult from RVO 
because this region is supplied with oxygen from the retinal vasculature, which was 25 
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relatively sparse compared with choroidal circulation.  In the current study, as shown in 
Figure 4, thinning and disorganization in the inner retina were seen within areas of 
nonperfusion, even if the outer retina appeared almost intact.  As discussed above, 
damage to the outer photoreceptor layer results in a moderate decrease in retinal 
function.  However, damage to the inner retina due to capillary nonperfusion causes a 5 
marked decrease in retinal function, which often leads to an absolute scotoma. 
     Previously, Finkelstein reported that eyes with ischemic ME caused by BRVO had a 
better visual prognosis than did those with perfused ME, and indicated that a broken FCR 
is frequently seen in ischemic ME [38].  However, other reports showed that BRVO 
accompanied by a broken FCR indicated a poor prognosis for VA [39-41], so the 10 
association between FCR status and VA remains controversial.  In the current study, 
eyes with either a broken or intact FCR achieved relatively good VA after the resolution of 
ME, and there were no statistically significant differences in VA.  However, mean foveal 
sensitivity of eyes with a broken FCR was significantly lower than that for eyes with an 
intact FCR.  In eyes with a broken FCR, marked foveal sensitivity loss was shown 15 
regionally to be consistent with the break in the FCR.  In the current study, we cannot 
make any conclusions regarding an association between FCR status and visual 
prognosis, although we do suggest that eyes with a broken FCR have significant loss of 
retinal sensitivity in the parafoveal region, which might cause some visual disturbance 
after resolution of the ME, even if complete recovery of VA is achieved. 20 
     One limitation of the current study is its small sample size.  To evaluate retinal 
function, we separated the macular area into an affected side and an unaffected side.  
However, this separation does not accurately reflect the area affected by RVO because 
of variations in retinal vasculature.  Our findings do suggest, however, that retinal 
function was substantially decreased in the area with a damaged photoreceptor layer due 25 
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to RVO.  However, retinal function within nonperfused areas was lethally decreased, 
even in eyes in which the outer retina was well preserved.  Moreover, we demonstrated 
that eyes with a broken FCR showed a marked loss of sensitivity in the area 
corresponding to the break in the FCR.  Such factors may be associated with persistent 
symptoms, such as blurred vision or relative scotoma, even after complete resolution of 5 
the ME and good recovery of VA. 
     Other limitations of the current study are the difference in the treatment regimens 
used and the wide range of the follow-up period.  Treatment and the duration of ME may 
influence the perfusion status or integrity of the photoreceptor layer.  In the current study, 
however, retinal function, integrity of the photoreceptor layer, and retinal perfusion status 10 
were all evaluated after complete resolution of the ME.  Further prospective studies are 
necessary to elucidate the effect of treatment and the duration of ME on retinal function 
and these pathologic conditions associated with RVO. 
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Figure legends 
 
Fig. 1.  Micro Perimeter 1 image shows retinal sensitivity at each stimulus site in 
decibels.  Fifty-seven stimulus points are located in the macular area covering the 
central 10 degrees, which is divided into three regions; the foveal region (central circle) 5 
consists of nine stimulus locations which covers the central 2 degrees and a minor region 
outside the fovea, the affected side, and the side unaffected by retinal vein occlusion, the 
latter two of which each consist of 24 stimulus locations. 
 
Fig. 2.  Fluorescein angiogram and Micro Perimeter 1 (MP1) image of an eye with 10 
branch retinal vein occlusion.  a Fluorescein angiogram shows an area of capillary 
nonperfusion and scars from the grid laser photocoagulation in the superior-temporal 
area of the macula.  b MP1 image shows that many 0 decibel (dB) points are 
concentrated in the superior-temporal area of the macula.  c MP1 results are 
superimposed onto the fluorescein angiogram on the basis of the following points: the 15 
fovea and two arteriovenous crossings that are located on opposite sides of the fovea.  
Based on this composite image, we can identify the retinal sensitivity and the status of 
retinal perfusion (perfusion versus nonperfusion) of each stimulus location.  In this 
particular case, the composite image shows the area of 0 dB to be well correlated with 
the area of capillary nonperfusion. 20 
 
Fig. 3.  A 65-year-old man had a six-week history of decreased visual acuity (VA) in the 
left eye (0.15 on Landolt chart) due to macular edema (ME) associated with hemi central 
retinal vein occlusion.  a Fundus photograph at the initial visit shows extensive retinal 
hemorrhage.  b The ME was resolved with intravitreal injections of bevacizumab.  At 13 25 
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months, VA in this eye had recovered to 1.2 on Landolt chart and foveal thickness was 
215 µm.  c Fluorescein angiogram shows minimal leakage from the retinal capillaries.  
d Sectional images obtained by optical coherence tomography (OCT) were made along 
long arrows shown in the retinal sensitivity map.  OCT sections show small defects of 
IS/OS (white arrows).  OCT images show a mostly intact inner and outer retina.  e 5 
Retinal sensitivity map obtained with the Micro Perimeter 1 shows focal areas with 
decreased sensitivity, consistent with the deteriorated IS/OS observed on the OCT 
images. 
 
Fig. 4.  A 69-year-old man had a one-week history of decreased visual acuity (VA) in the 10 
right eye (0.4 on Landolt chart) due to macular edema (ME) associated with hemi central 
retinal vein occlusion.  a Fundus photograph at the initial visit shows extensive retinal 
hemorrhage.  The ME was resolved with the treatment by intravitreal injections of 
bevacizumab.  b At 22 months after the initial visit, VA in this eye was 0.6 on Landolt 
chart and foveal thickness was 213 µm.  c Fluorescein angiogram shows a large area of 15 
capillary nonperfusion (NPA), which involves the foveal region.  d, Sectional images with 
optical coherence tomography (OCT) were obtained along the long arrows shown in the 
retinal sensitivity map.  An OCT image in the perfused region of the retina (first row) 
shows intact structure of the retina.  OCT image in NPA (fourth row) shows thinning and 
disorganization of the inner retina (black arrows) and relatively well preserved outer 20 
retina.  e Retinal sensitivity map obtained with the Micro Perimeter 1 shows markedly 
decreased retinal sensitivity in the inferior macular area, consistent with the NPA 
detected by fluorescein angiogram. 
 
Fig. 5.  Histograms showing the numbers of measurement points with various retinal 25 
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sensitivities measured with the Micro Perimeter 1 on the side of the macula affected by 
retinal vein occlusion.  a Measurement points located in the area of capillary 
nonperfusion, which show the intact junctions between inner and outer segments of the 
photoreceptors (IS/OS).  b Measurement points located in the perfused area, which also 
show deterioration of the IS/OS.  c Measurement points located in the area of capillary 5 
nonperfusion, showing deteriorated IS/OS.  d Measurement points located in the 
perfused area, showing intact IS/OS. 




Table 1  Clinical characteristics of patients after resolution of macular edema 
associated with retinal vein occlusion 
Number of patients and eyes      24 (24 eyes) 
Age (years)      66.8 ± 10.1 
Gender (men/women)     10/14 
Hypertension (number of patients)    12 
Lens status (phakia/pseudophakia)   19/5 
Initial visual acuity (logMAR)     0.49 ± 0.33 
Visual acuity at time of MP1 measurement (logMAR)  0.07 ± 0.16 
Initial foveal thickness (µm)    554 ± 97 
Foveal thickness at time of MP1 measurement (µm)  210 ± 30 
Duration of macular edema (months) 6.7 ± 4.8 
Duration from resolution of macular edema to MP1 measurement (months) 11.5 ± 6.5 
Duration of follow-up (months) 31.6 ± 26.7 
Type of retinal vein occlusion (number of eyes)     
   Branch retinal vein occlusion     17 
   Hemi central retinal vein occlusion    7 
logMAR = logarithm of the minimum angle of resolution; MP1 = Micro Perimeter 1 
Duration of macular edema was defined as the duration from the initial symptom to the initial 
resolution of macular edema. 
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Table 2  Condition of IS/OS and retinal sensitivity of eyes after resolution of macular 
edema associated with retinal vein occlusion 
Retinal area Number of points  Retinal sensitivity (dB) 
Unaffected side       
     Whole 576  15.5 ± 3.5 
     Complete IS/OS 548  15.7 ± 3.3 
     Deteriorated IS/OS 28  11.1 ± 3.8 
    
Affected side    
     Whole 576  8.9 ± 6.6
∗ 
     Complete IS/OS 466  10.1 ± 6.4
† 
     Deteriorated IS/OS 110  3.8 ± 4.8
‡§ 
IS/OS = junction between photoreceptor inner and outer segments; dB = decibel 
∗p<0.001, compared with values of whole points on unaffected side. 
†p<0.001, compared with values of complete IS/OS points on unaffected side. 
‡p<0.001, compared with values of deteriorated IS/OS points on unaffected side. 
§p<0.001, compared with values of complete IS/OS points on affected side. 
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Table 3  Condition of IS/OS, retinal sensitivity and retinal perfusion status of 
eyes after resolution of macular edema associated with retinal vein occlusion 
 Retinal perfusion status   
Condition of IS/OS NPA PA Total 
    
Deteriorated 28 68 96 
   (number of points/dB) 0.0 ± 0.0 5.1 ± 4.9
∗ 3.6 ± 4.7 
    
Intact 74 286 360 
   (number of points/dB) 0.5 ± 1.5 12.2 ± 5.2
∗† 9.8 ± 6.7 
    
Total 102 354 456 
   (number of points/dB) 0.3 ± 1.3 10.9 ± 5.9 8.5 ± 6.8 
IS/OS = junction between photoreceptor inner and outer segments; dB = decibel; 
NPA = capillary nonperfusion area; PA = perfused area 
∗p<0.001, compared with values within NPA with intact IS/OS points. 
†p<0.001, compared with values within PA with deteriorated IS/OS points. 




Table 4  Retinal sensitivity in the foveal region of eyes with broken or intact foveal 
capillary ring 
 Eyes with  Eyes with   
 broken FCR intact FCR P value 
Number of eyes 10 9 - 
    
Age (years) 65.7 ± 13.0 67.9 ± 9.7 0.57 
    
Initial visual acuity (logMAR) 0.69 ± 0.33 0.38 ± 0.29 0.13 
    
Initial foveal thickness (µm) 561 ± 106 551 ± 106 0.85 
    
Visual acuity after resolution of 
macular edema (logMAR) 
0.15 ± 0.12 0.04 ± 0.21 0.055 
    
Foveal thickness after resolution of 
macular edema (µm) 
226 ± 33 199 ± 22 0.066 
    
Type of retinal vein occlusion     
       (number of eyes)    
   Branch retinal vein occlusion 6 7  
   Hemi central retinal vein occlusion 4 2 0.41 
    
Retinal sensitivity in foveal region (dB) 10.9 ± 6.5 13.7 ± 4.9 <0.001  
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